Mark Gorelick
Founder Health Technology Consultant (Available for Full-time Roles) @Xphys Technologies Inc
Signup · Get unlimited contacts
WORK HISTORY
Founder Health Technology Consultant (Available for Full-time Roles) @Xphys Technologies Inc
CA
XPhys Technologies Inc.(EST 2017) is a global biomedical AI consulting firm specializing in product development strategy for healthcare SaaS platforms and medical device companies, focused on productizing AI and agentic workflows to minimize administrative burdens and improve health outcomes.Responsibilities:As Founder and Managing Partner, I lead operations and business growth, driving innovation at the intersection of digital health, AI strategy, and advanced hardware/software solutions. I leverage deep expertise in AI-enhanced product design, biometric modeling, and go-to-market delivery to help clients build validated, high-impact technologies.Key Achievements:• Direct product development strategy for healthcare SaaS platforms and medical device partners globally, leveraging AI strategy and agentic workflows to accelerate cycles, improve product-market fit, and streamline pathways from concept validation through regulatory clearance and launch.• Architect AI-enhanced frameworks that integrate agentic workflows into core processes, enabling teams to automate biometric modeling, clinical validation, and benchmarking—reducing time-to-market for complex digital health solutions.• Lead advisory engagements with product leadership at Fortune 500 health companies, delivering end-to-end strategy for regulated hardware/software solutions where AI-driven insights and connected devices create differentiated value across B2B and B2C markets.• Drive AI strategy consulting focused on helping healthcare SaaS and medical device organizations embed intelligent automation into workflows, from prototyping and data simulation through iterative testing and regulatory submissions.• Build strategic partnerships with manufacturers and platforms across North America, Europe, and Asia, demonstrating how agentic workflows transform product innovation, validation, and go-to-market execution.
EDUCATION
Dalhousie University
B.Sc., Kinesiology
Dalhousie University
M.Sc., Kinesiology
University of Wollongong
Ph.D., Biomedical Science
SKILLS
ABOUT MARK GORELICK
I architect AI-powered digital health platforms that transform how organizations deliver preventive care at scale. As Chief Product Officer with a PhD in Biomedical Science, I lead the strategic development of integrated ecosystems spanning healthcare SaaS platforms, connected devices, and clinical-grade solutions.My expertise centres on building comprehensive platforms where AI strategy, biometric intelligence, and software architecture converge. I\'ve developed ecosystems combining healthcare SaaS with wearable networks, translating physiological biomarkers into scalable solutions across B2B, B2C, and D2C markets.I\'ve delivered end-to-end platform strategy across the digital health spectrum, from cloud-based software and data analytics infrastructure to connected health devices. In my most recent role I led the FDA 510(k) clearance of the first vascular biometric health monitor and supporting platform.I build global cross-functional teams bridging AI, engineering, data science, and commercial strategy. I thrive translating scientific complexity into strategic clarity and ambiguity into measurable outcomes at the intersection of science, AI innovation, and executive leadership:Product vision and roadmap, AI and biometric algorithm strategy, regulated product development and FDA 510(k), clinical validation, HIPAA-compliant SaaS platforms, user-centric design, commercialization and partnerships, cross-functional leadership, and remote team scaling. Launched CONNEQT Pulse, the world’s first FDA‑cleared vascular biometric monitor, achieving rapid market adoption in Q1. Built the CONNEQT Health brand and ecosystem, earning CES Innovation Award and PCMag Best of CES. Released CONNEQT mobile apps with sustained 4+ star ratings across iOS and Android. Drove a 150% increase in Cardiex Ltd. revenue within four years, fueling rapid growth and new market entry. Led development of a breakthrough wearable arterial screening device, recognized by MedTech Innovator Accelerator and awarded $525K NIH RADx Tech Challenge, validating SphygmoCor’s leadership in noninvasive arterial health.🤝 Established trusted partnerships with leading pharma, clinical trial, and population health organizations. 9 major awards across 4 product lines during Mio Global tenure 5 awards for PAI Slice during PAI Health period 3 awards for CONNEQT Pulse during Cardiex period Total: 17+ major industry recognitions spanning CES, ISPO, Red Dot, PCMag, and NIH
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.